Merck And BGI Sign Global Deal Focused On Biomarkers, Genomics
This article was originally published in PharmAsia News
Executive Summary
After announcing the intent to form a partnership a year ago, Merck & Co. announced Sept. 13, a collaboration with BGI (formerly the Beijing Genomics Institute) for discovery and development of biomarkers and genomic technologies